amivantamab,lazertinib
janssen,yuhan corp
['lung', 'lazertinib', 'rybrevant', 'nsclc', 'sclc', 'janssen']
#janssen at #asco23: #rybrevant and #lazertinib combination therapy shows promising long-term results in egfr-mutated #nsclc #pharma #pharmaceutical #asco2023 #lungcancer #medtwitter #oncotwitter #medicine #medtwitter #science #research #technology #news
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma